Substance / Medication

Cefapirin

Overview

Active Ingredient
cephapirin
RxNorm CUI
2238

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Prevention of renal stone disease recurrence. A systematic review of contemporary pharmaceutical options.
Sfoungaristos Stavros, Gofrit Ofer N, Yutkin Vladimir et al. · Expert Opin Pharmacother · 2015
PMID: 25881654Meta-Analysis
Strategy to control catheter encrustation with citrated drinks: a randomized crossover study.
Khan Azhar, Housami Fadi, Melotti Roberto et al. · J Urol · 2010
PMID: 20171661RCT
Pathogenesis ofInfection.
Armbruster Chelsie E, Mobley Harry L T, Pearson Melanie M · EcoSal Plus · 2018
PMID: 29424333ReviewFull text (PMC)
From Catheter to Kidney Stone: The Uropathogenic Lifestyle of Proteus mirabilis.
Norsworthy Allison N, Pearson Melanie M · Trends Microbiol · 2017
PMID: 28017513ReviewFull text (PMC)
Assessment of the Usefulness of Cefapirin and Cefalonium Disks for Susceptibility Testing ofIsolates from Bovine Mastitis.
Harada Kazuki, Irie Shieri, Ohnishi Mamoru et al. · Antibiotics (Basel) · 2020
PMID: 32326215OtherFull text (PMC)
Base-catalyzed hydrolysis and speciation-dependent photolysis of two cephalosporin antibiotics, ceftiofur and cefapirin.
Ribeiro Alyson R, Lutze Holger V, Schmidt Torsten C · Water Res · 2018
PMID: 29428778Other
Ecotoxicity of the two veterinarian antibiotics ceftiofur and cefapirin before and after photo-transformation.
Ribeiro Alyson R, Sures Bernd, Schmidt Torsten C · Sci Total Environ · 2018
PMID: 29734632Preclinical
Prednisolone and cefapirin act synergistically in resolving experimental Escherichia coli mastitis.
Sipka Anja, Gurjar Abhijit, Klaessig Suzanne et al. · J Dairy Sci · 2013
PMID: 23684040Preclinical
Development and validation of an ultra high performance liquid chromatography tandem mass spectrometry method for determination of 10 cephalosporins and desacetylcefapirin in milk.
Hou Xiao-Lin, Wu Yin-Liang, Lv Yan et al. · J Chromatogr B Analyt Technol Biomed Life Sci · 2013
PMID: 23747425Preclinical

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Cefapirin (substance)
SNOMED CT
87303007
UMLS CUI
C0007737
RxNorm CUI
2238

Clinical Data

This intervention maps to 9 entities in the Healos knowledge graph.

9
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.